Hepsera and Arrhythmias - a phase IV clinical study of FDA data

Summary:

Arrhythmias is reported as a side effect among people who take Hepsera (adefovir dipivoxil), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Combivent, and have Hepatocellular carcinoma.

The phase IV clinical study analyzes which people have Arrhythmias when taking Hepsera. It is created by eHealthMe based on reports of 3,102 people who have side effects when taking Hepsera from the FDA, and is updated regularly.

What is Hepsera?

Hepsera has active ingredients of adefovir dipivoxil. It is often used in hepatitis b. eHealthMe is studying from 3,113 Hepsera users. Check the latest studies of Hepsera.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,754 drugs and 4,841 conditions by eHealthMe. Check the latest studies of Arrhythmias.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 27, 2026

3,102 people reported to have side effects when taking Hepsera.
Among them, 14 people (0.45%) have Arrhythmias.

Among these 14 people:

How long have people been on Hepsera when they have Arrhythmias? *

What is the gender of people who have Arrhythmias when taking Hepsera? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Arrhythmias when taking Hepsera? *

What are other drugs people take besides Hepsera? *

What are other side effects people have besides Arrhythmias? *

Hypotension (abnormally low blood pressure): 7 people, 50.00%
Atelectasis (partial or complete collapse of the lung): 5 people, 35.71%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 4 people, 28.57%
Nausea And Vomiting: 4 people, 28.57%
Speech Impairment (Adult) (inability to speak (adult)): 3 people, 21.43%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 21.43%
Fatigue (feeling of tiredness): 3 people, 21.43%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 21.43%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 21.43%
Blood Creatine Phosphokinase Increased: 2 people, 14.29%

What are the existing conditions these people have? *

Hiv Infection: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Hepatocellular Carcinoma (liver cancer): 2 people, 14.29%
Hepatitis C: 1 person, 7.14%
Drug Resistance (reduction in effectiveness of a drug): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Hepsera and have Arrhythmias?

- Check whether Arrhythmias is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hepsera:

Hepsera (3,113 reports)

Arrhythmias treatments and more:

Arrhythmias (177,909 reports)

Browse all side effects of Hepsera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arrhythmias:

Arrhythmias (2,754 drugs)

Browse all the conditions that are associated with Arrhythmias:

Arrhythmias (4,841 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adefovir dipivoxil (the active ingredients of Hepsera) and Hepsera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.